Content sponsored by Zoetis
Adam Christman, DVM, MBA: Hello and invited to a Great treatment guaranteed to marque you larn and recognize assorted perspectives successful veterinary medicine. My sanction is Dr. Adam Christman dvm360's, Chief Veterinary Officer. On behalf of our friends astatine Zoetis. Welcome to our insights sheet discussion, A Reference Lab Revolution. This treatment volition stock cases surrounding the tract of objective pathology arsenic good arsenic anatomical pathology and microbiology. I americium honored to beryllium facilitating treatment with our friends and wherefore don't we spell up and present ourselves. We'll commencement implicit here.
Carolyn Grimes, DVM, DACVP (Clinical Pathology): I'm Dr. Carolyn Grimes. I'm a objective pathologist and I'm the aesculapian director.
Shelley Rankin, PhD: I'm Dr. Shelley Rankin. I'm a microbiologist than the manager of Microbiology and Molecular Medicine.
Laura Brandt, DVM, MS, DACVP (Clinical Pathology): I'm Dr. Laura Brandt. I'm besides a objective pathologist, and I'm the Director of Clinical Pathology.
Katherine Gailbreath, DVM, PhD, DACVP: And I'm Dr. Katherine Gailbreath. I'm an anatomic pathologist and method manager.
Adam Christman, DVM, MBA: Thank you for joining america friends. This is gonna beryllium fantastic. This treatment is going to person respective components. First, we're going to larn a small spot much astir the Zoetis Reference Lab. Then we're going to delve into a small spot further astir the CBC, modulation connected implicit a small spot to microbiology, and past we're going to sermon a small spot astir dermatopathology. So up next, we're going to chat with Dr. Carolyn Grimes. And we're going to larn a small spot astir what's caller and what's going connected with our friends astatine Zoetis Reference Labs.
English (US)